title: Febrile neutropenia: a critical review of the initial management.
abstract: The present state of the art for management of patients with febrile neutropenia has been reviewed as well as potential ways to improve it in the future. A major advance has been the possibility to predict, accurately and early, the risk of complications and death in those patients. While the algorithm for therapy in low-risk patients is presently straightforward, significant progresses are needed for patients who are at higher risk of presenting severe complications.
authors.affiliation: Department of Medicine, Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles, Brussels, Belgium. jean.klastersky@bordet.be
authors.forename: Jean
authors.initials: J
authors.lastname: Klastersky
authors.forename: Ahmad
authors.initials: A
authors.lastname: Awada
authors.forename: Mariane
authors.initials: M
authors.lastname: Paesmans
authors.forename: Mickael
authors.initials: M
authors.lastname: Aoun
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000150:complications* / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D009369:Neoplasms / Q000150:complications; D009503:Neutropenia / Q000150:complications* / Q000188:drug therapy* / Q000453:epidemiology
chemical_list: D000900:Anti-Bacterial Agents